During the past decade, University of Texas MD Anderson Cancer Center - Unit 432 Thoracic Head and Neck Medical Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Texas MD Anderson Cancer Center - Unit 432 Thoracic Head and Neck Medical Oncology" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of Texas MD Anderson Cancer Center - Unit 432 Thoracic Head and Neck Medical Oncology" are "Non-small Cell Lung Cancer" (2 trials), "Advanced Solid Tumors" (1 trials), "Breast Cancer" (1 trials), "Cowden Syndrome" (1 trials) and "Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "University of Texas MD Anderson Cancer Center - Unit 432 Thoracic Head and Neck Medical Oncology" in a lesser frequency.

Most popular intervention types in "University of Texas MD Anderson Cancer Center - Unit 432 Thoracic Head and Neck Medical Oncology" are "Drug" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "BEZ235" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials), "Durvalumab" (1 trials) and "EGF816" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Texas MD Anderson Cancer Center - Unit 432 Thoracic Head and Neck Medical Oncology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "University of Texas MD Anderson Cancer Center - Unit 432 Thoracic Head and Neck Medical Oncology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of Texas MD Anderson Cancer Center - Unit 432 Thoracic Head and Neck Medical Oncology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Texas MD Anderson Cancer Center - Unit 432 Thoracic Head and Neck Medical Oncology, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".